1. Dual genetic absence of STAT6 and IL-10 does not abrogate anti-hyperglycemic effects of Schistosoma mansoni in streptozotocin-treated diabetic mice.
- Author
-
Osada Y, Fujiyama T, Kamimura N, Kaji T, Nakae S, Sudo K, Ishiwata K, and Kanazawa T
- Subjects
- Animals, Biomphalaria, Blood Glucose metabolism, Diabetes Mellitus, Experimental parasitology, Diabetes Mellitus, Experimental prevention & control, Diabetes Mellitus, Type 1 chemically induced, Diabetes Mellitus, Type 1 parasitology, Gene Expression Regulation, Injections, Intraperitoneal, Interleukin-10 metabolism, Interleukin-13 genetics, Interleukin-13 metabolism, Interleukin-4 genetics, Interleukin-4 metabolism, Islets of Langerhans pathology, Lymph Nodes cytology, Lymph Nodes immunology, Male, Mice, Mice, Inbred C57BL, Mice, Inbred ICR, Mice, Inbred NOD, Mice, Knockout, STAT6 Transcription Factor metabolism, Schistosomiasis mansoni blood, Specific Pathogen-Free Organisms, Spleen immunology, Streptozocin administration & dosage, T-Lymphocytes immunology, Diabetes Mellitus, Experimental genetics, Diabetes Mellitus, Type 1 genetics, Interleukin-10 genetics, STAT6 Transcription Factor genetics, Schistosomiasis mansoni complications
- Abstract
Schistosoma mansoni (Sm) is known to exert protective effects against various allergic and autoimmune disorders. It has been reported that this parasite protects NOD mice from spontaneous type 1 diabetes (T1D) and ameliorates streptozotocin (STZ)-induced T1D in wild-type mice. Here, we tried to clarify the anti-diabetic mechanisms of Sm in the latter model. Sm infection partially prevented the degradation of pancreatic islets and hyperglycemia in multiple low-dose (MLD) STZ-treated mice. Neither Treg cell depletion nor genetic absences of IL-10 and/or STAT6 abrogated the anti-hyperglycemic effects of Sm. Among M2 macrophage markers, Arg-1 and Ym1, but not Retnla, remained up-regulated in the pancreatic lymph nodes and in the spleens of STAT6/IL-10 double deficient (DKO) mice. Collectively, it is suggested that Sm exerts anti-diabetic effects on this experimental T1D model via Treg/IL-4/IL-13/IL-10-independent mechanisms. Augmented expressions of Arg-1 and Ym1 in the lymphoid organs adjacent to pancreas may be relevant to the anti-diabetic effects of Sm., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF